# OnCo record paper-study-0201-blood-2006 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-study-0201-blood-2006/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-study-0201-blood-2006" ;
  schema:name "Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial"@en ;
  schema:description "The primary report of Study 0201: adding histamine dihydrochloride to low-dose interleukin-2 after consolidation improved leukaemia-free survival in acute myeloid leukaemia, with 40 percent against 26 percent leukaemia-free at three years in first remission."@en ;
  schema:url <https://onco.cc/key-papers/paper-study-0201-blood-2006/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood-2005-10-4073>, <https://pubmed.ncbi.nlm.nih.gov/16556892/>, <https://clinicaltrials.gov/study/NCT00003991> ;
  schema:sameAs <https://doi.org/10.1182/blood-2005-10-4073> ;
  schema:datePublished "2006"^^xsd:gYear ;
  schema:author "Brune M, Castaigne S, Catalano J, et al." ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/histamine-dihydrochloride/>, <https://onco.cc/drugs/aldesleukin/> ;
  onco:trials <https://onco.cc/trials/study-0201/> ;
  onco:journals <https://onco.cc/journals/blood/> .